PPB - Services

Complaints, Feedback and Enquiry

๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐š๐ง๐ ๐๐จ๐ข๐ฌ๐จ๐ง๐ฌ ๐๐จ๐š๐ซ๐ ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž๐ฌ ๐ƒ๐ž๐ž๐ฉ๐ž๐ซ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐‚๐จ๐ฅ๐ฅ๐š๐›๐จ๐ซ๐š๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐๐ข๐š


Nairobi, Kenya: The Pharmacy and Poisons Board (PPB) heldย  a high-level meeting with the Indian High Commissioner to Kenya, Mr. Sushil Prasad, and the Head of Commerce, Mr. Rishabh Kumar Rewal, on Tuesday 2nd July 2025, to strengthen bilateral cooperation in the pharmaceutical sector.

The meeting, chaired by Dr. Ahmed Mohamed, Director of Health Products and Technologies, on behalf of PPB CEO Dr. F. M. Siyoi, focused on enhancing regulatory capacity and exploring opportunities for technical collaboration between the two countries.

Key areas of discussion included capacity building in regulatory functions such as product registration, vaccine lot release, and inspectorate operations; technology transfer to support local vaccine manufacturing; and the potential for mutual agreements with Indiaโ€™s Central Drugs Standard Control Organization and the Indian Pharmacopoeia.

The engagement aimed to deepen Kenyaโ€“India collaboration in support of a robust and self-reliant pharmaceutical sector in Kenya.

Author

Public Relations

Leave a comment

Your email address will not be published. Required fields are marked *